Neuroblastoma, overall, has an average mean KIT expression similar to most other solid tumors, but like kidney, lung, breast, medulloblastoma, ependymoma, and CNS/PNET tumors, it has a substantial percentage (>5%) sample with high KIT expression (higher than mean KIT expression in AML). This evidence concerns the gene KIT and medulloblastoma.